首页> 外文OA文献 >Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy

【2h】

Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy

机译：人参多糖改变了肠道微生物，提高了抗蠕动细胞死亡1 /编程细胞死亡配体1（抗PD-1 / PD-L1）免疫疗法的抗肿瘤效果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jumin Huang; Di Liu; Yuwei Wang; Liang Liu; Jian Li; Jing Yuan; Zhihong Jiang; Zebo Jiang; WL Wendy Hsiao; Haizhou Liu; Imran Khan; Ying Xie; Jianlin Wu; Yajia Xie; Yizhong Zhang; Yu Fu; Junyi Liao; Wenjun Wang; Huanling Lai; Axi Shi; Jun Cai; Lianxiang Luo; Runze Li; Xiaojun Yao; Xingxing Fan; Qibiao Wu; Zhongqiu Liu; Peiyu Yan; Jingguang Lu; Mingrong Yang; Lin Wang; Yabing Cao; Hong Wei; Elaine Lai-Han Leung;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management [J] . John Shen, Jason Chang, Melody Mendenhall, Therapeutic advances in medical oncology. . 2018,第3期

机译：由抗程序性细胞死亡1（PD-1）和抗程序性细胞死亡配体1（PD-L1）免疫疗法引起的多种皮肤不良反应：临床特征和管理
2. Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death-ligand 1 (PD-L1) axis in post-transplant lymphoproliferative disorders: association with Epstein-Barr virus, PD-L1 copy number alterations, and outcome [J] . Veloza Luis, Teixido Cristina, Castrejon Natalia, Histopathology: Official Journal of the British Division of the International Academy of Pathology . 2019,第6期

机译：后移植后淋巴抑制性疾病中的编程细胞死亡1（PD1）/编程的细胞死亡配体1（PD-L1）轴的临床病理评价：与Epstein-Barr病毒相关联，PD-L1拷贝数改变和结果
3. Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing (vol 36, pg 633, 2018) [J] . Journal of Clinical Oncology . 2018,第16期

机译：对非小细胞肺癌的患者具有靶向下一代测序的非小细胞肺癌（Vol 36）的患者响应反编程细胞死亡（Pd）-1和抗程序死亡 - 配体1（PD-L1）阻断的分子决定因素 PG 633,2018）
4. Molecular dynamics of the immune checkpoint Programmed Cell Death Protein I, PD-1: Conformational changes of the BC-loop upon binding of the ligand PD-L1 and the monoclonal antibody nivolumab [C] . Bernhard Roither, Chris Oostenbrink, Wolfgang Schreiner IEEE International Conference on Bioinformatics and Biomedicine . 2019

机译：免疫检查点的分子动力学程序性细胞死亡蛋白I，PD-1：配体PD-L1与单克隆抗体nivolumab结合后BC环的构象变化
5. Studies of cell migration and programmed cell death: characterization and analysis of scattershot, a mutation disrupting germ cell migration and programmed cell death in Drosophila melanogaster. [D] . Kamps, Angela Renee. 2008

机译：细胞迁移和程序性细胞死亡的研究：散点图的表征和分析，果蝇的突变破坏了生殖细胞的迁移和程序性细胞死亡。
6. Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management [O] . John Shen, Jason Chang, Melody Mendenhall, 2018

机译：由抗程序性细胞死亡1（PD-1）和抗程序性细胞死亡配体1（PD-L1）免疫疗法引起的多种皮肤不良反应：临床特征和管理
7. Adverse cardiovascular complications following prescription of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) inhibitors [O] . Jiandong Zhou, Gary Tse, Xiansong Wang, 2020

机译：在编程的细胞死亡1（PD-1）和编程的细胞死亡配体1（PD-L1）抑制剂中进行不良心血管并发症

Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅